Riverbend Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.5M Sell
5,656
-48
-0.8% -$12.7K 0.68% 41
2026
Q2
$1.45M Buy
5,704
+268
+5% +$62.5K 0.73% 41
2026
Q1
$1.33M Buy
5,436
+182
+3% +$42.4K 0.76% 34
2025
Q4
$1.09M Buy
5,254
+424
+9% +$83.8K 0.68% 42
2025
Q3
$896K Buy
4,830
+24
+0.5% +$4.11K 0.63% 41
2025
Q2
$734K Sell
4,806
-22
-0.5% -$3.38K 0.56% 49
2025
Q1
$801K Buy
4,828
+215
+5% +$33.6K 0.72% 43
2024
Q4
$669K Hold
4,613
– – 0.6% 45

Other funds holding JNJ

Riverbend Wealth Management's JNJ Position: Q3 2026 in Review

Riverbend Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.84% in Q3 2026, selling an estimated $12.7K and leaving 5,656 shares worth $1.5M. The position accounts for 0.68% of the portfolio, ranked #41.

Riverbend Wealth Management first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,737 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Riverbend Wealth Management held 5,656 shares of Johnson & Johnson worth $1.5M as of Q3 2026.
  • Riverbend Wealth Management sold 48 Johnson & Johnson shares in Q3 2026, an estimated $12.7K.
  • Johnson & Johnson made up 0.68% of Riverbend Wealth Management's portfolio in Q3 2026, its #41 holding.
  • Riverbend Wealth Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,737 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Riverbend Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.